Navigation Links
Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity
Date:10/5/2011

PARIS, Oct. 5, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today the publication of the pivotal Phase III TEMSO study with investigational once-daily oral medication teriflunomide in The New England Journal of Medicine (NEJM).  Results showed that teriflunomide at the 14mg dosage significantly reduced the annual relapse rate, reduced disability progressions and improved several magnetic resonance imaging (MRI) measures of disease activity, including new or worsening brain lesions.  Teriflunomide has a well-characterized safety profile, with a similar proportion of trial participants reporting adverse events compared to placebo.

"The TEMSO data demonstrate the effect of teriflunomide in terms of reducing relapse rates, disability progression and Magnetic Resonance Imaging (MRI) lesions," said Dr. Paul O'Connor, Director of the MS Clinic at St Michael's Hospital, Toronto, Canada and principal investigator in the TEMSO study.  "These results, sustained over two years, provide clinically meaningful data for teriflunomide."

The two-year TEMSO (TEriflunomide Multiple Sclerosis Oral) trial involved 1,088 people with relapsing forms of MS from 126 centers across 21 countries. TEMSO is the first study from a broad clinical development program that includes more than 4,000 trial participants in 36 countries and is one of the largest and broadest clinical programs of any oral MS agent under development, with five Phase III clinical trials either completed or underway.

"The publication of the teriflunomide results in the New England Journal of Medicine is an exciting milestone as we continue the development of our product," said Dr. Elias Zerhouni, President, Global Research & Development, Sanofi. "As we continue our commitment t
'/>"/>

SOURCE Sanofi; Genzyme
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger
2. Positive Phase III Data on Bayers Investigational Drug Radium-223 Chloride Show Significant Increase in Overall Survival
3. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
4. Bayer to Present New Data Evaluating Investigational Oncology Compounds at 2011 ECCO-ESMO Congress
5. Boehringer Ingelheim Broadens Its Breast Cancer Clinical Trial Program for the Investigational Compound Afatinib
6. FDA Grants Fast Track Designation to Bayers Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
7. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
8. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
9. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
10. Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Associations 71st Annual Scientific Sessions
11. Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... the Netherlands , May 5, ... developing lower esophageal sphincter (LES) stimulation therapy for ... safety and efficacy results. The results demonstrated an ... and regurgitation and the "gold-standard" esophageal acid exposure ... elimination of dependence on daily PPI medications. ...
(Date:5/5/2015)... LYME, Conn. , May 5, 2015  American ... lab equipment in North America, has named industry veteran ... of Business Development. Becorest will be based out of ... where her role will include expanding the company,s west ... strategic partnership opportunities. "ALT has been the ...
(Date:5/5/2015)... -- IQPC,s 19 th Software Design for Medical Devices ... Summit Mr. Phani Bidarahalli , GM & Head of ... expert speaker faculty including senior executive from GE Healthcare, Philips ... The Hotel Kabuki in San Francisco . ... the event website, which can be accessed by visiting ...
Breaking Medicine Technology:Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3ALT Names Anggie Becorest Senior Vice President of Business Development 2Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2
... ROCKVILLE, Md., Oct. 24, 2011 Vanda Pharmaceuticals Inc. ... has named Bob Repella as Senior Vice President, Chief ... has more than 25 years of experience in the ... sales, new product development and commercial operations.   ...
... 24, 2011 Pinnacle Biologics, Inc., a privately held ... an Orphan Drug Designation (ODD) for their product PHOTOFRIN® ... in the treatment of Malignant Pleural Mesothelioma. ... the lining of the lungs. It is a rare, ...
Cached Medicine Technology:Vanda Pharmaceuticals Appoints Chief Commercial Officer 2Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 2Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 3Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 4
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... mission-focused company serving the federal government, today announced ... (CCSi). CCSi provides solutions exclusively to federal ... extensive experience in cyber security, health services, and ... processes and industry-relevant credentials as a Third Party ...
(Date:5/5/2015)... 05, 2015 Rare Genomics Institute ... new study aimed at determining how crowdfunding can promote ... an international non-profit providing rare disease patients with access ... to scientists and researchers, and help for payment of ... am excited to see how crowdfunding will not only ...
(Date:5/5/2015)... 2015 With Mother's Day, graduation ... of the country's leading organic vegetable brands, knows ... across the country. What to eat? There’s no ... or spend hours browsing Pinterest – Josie's Organics ... . , The new recipes are sophisticated ...
(Date:5/5/2015)... What do you get when you combine one ... mountaineers and one of the world’s greatest causes? The world’s ... by Marc Middleton, which follows world-renowned mountaineer Chris Warner as ... frozen summit of Mount Kilimanjaro. , “This film is ... action. Viewers are moved to ask, ‘What can I do?’” ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Specialty ... collaborating with American Eagle Outfitters on a collection ... natural beauty. , For the debut five-piece ... Aerie by American Eagle ; the retailer's ... body-image campaign, called "Aerie REAL," uses models of ...
Breaking Medicine News(10 mins):Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 3Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3
... common vision problems can find glasses or contact lenses fairly ... affect the focus of light have more limited options and ... , At the University of Houston,s College of Optometry, ... latter population,s long-underserved needs by developing custom contact lenses. , ...
... The Certification Commission for Healthcare Information Technology (CCHIT®) today announced ... is a CCHIT Certified® 08 Ambulatory EHR, and meets the ... Ambulatory EHRs are designed for physician offices and clinics where ... ...
... May 13 President Barack Obama and Speaker ... meeting on health care reform this morning at the ... Joe Biden, House Majority Leader Steny Hoyer, and Chairmen ... are the Speaker,s remarks; the White House will provide ...
... - Exclusive videos by HealthiNation to feature Best Hospitals in ... May 13 U.S. News and ... today announced an exclusive web video series featuring a selection ... a ranking in U.S. News ,s prestigious 2009 ...
... In recognition of National Cystic Fibrosis Awareness ... to ring the closing bell of the New ... the leading organization in the United States devoted ... genetic disease.C. Richard Mattingly, executive vice president and ...
... levelsWASHINGTON, May 13 Eight million Americans are covered ... of more than 31 percent since last year, a ... (AHIP) finds. Health Savings Accounts were authorized starting ... a periodic census of its members participating in the ...
Cached Medicine News:Health News:UH optometrists make custom contact lenses for long-underserved patients 2Health News:UH optometrists make custom contact lenses for long-underserved patients 3Health News:UH optometrists make custom contact lenses for long-underserved patients 4Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 2Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 3Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 4Health News:Pelosi: Health Care Legislation Will Be on the House Floor by the End of July 2Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 2Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 3Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 4Health News:Cystic Fibrosis Foundation Rings Bell to Close New York Stock Exchange 2Health News:Health Savings Account Enrollment Reaches Eight Million 2
Inquire...
... a floor model centrifuge to do, but just ... PR-7000M delivers up to 50% more force in ... faster and more efficiently., Tremendous Capacity ... liters, PR-7000M accommodates 30 microplates, up to 408 ...
Inquire...
Inquire...
Medicine Products: